欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体
Anti-CSF1R mAbs [CS7](MABL-3656)
  • Anti-CSF1R mAbs [CS7](MABL-3656)

Anti-CSF1R mAbs [CS7](MABL-3656)

简要描述:

For Research Use Only. Not for diagnostic or therapeutic use.

产品参数:

Cat. No.:MABL-3656

Application:functional assay, in vitro, in vivo, Block

Isotype:Engineer antibody

Species Reactivity:Mouse

Clone No.:CS7

产品价格:¥0

详细介绍
Cat. No.
MABL-3656
Application
functional assay, in vitro, in vivo, Block
Isotype
Engineer antibody
Species Reactivity
Mouse
Clone No.
CS7
From
Recombinant Antibody
Specificity
This antibody binds the extracellular domains I and II of mouse CSF-1R. This protein is a tyrosine-protein kinase that acts as a cell-surface receptor for CSF1 and IL34 and plays an essential role in the regulation of survival, proliferation and differentiation of hematopoietic precursor cells, especially mononuclear phagocytes, such as macrophages and monocytes.
Alternative Names
CD115; CSF-1R; CSF-1-R; M-CSF-1R; FMS; c-FMS; Csfmr; Macrophage colony-stimulating factor 1 receptor; CSF-1 receptor; Proto-oncogene c-Fms
UniProt
P09581
Immunogen
/
Application Notes
This antibody was shown to inhibit the binding of both CSF-1 and IL-34 to murine CSF-1R. By blocking ligand binding, this antibody blocks downstream activation of the receptor preventing phosphorylation of the CSF-1R receptor subsequently its activation. In vitro, monocytic to macrophage differentiation was impeded in the presence of CS7 (Yanxia Li et al, Mol Cancer Ther (2011) Abstract C224; EP3380521). In vitro, it prevented monocyte proliferation and macrophage differentiation with IC50s of 0.1 nM and 0.75 nM, respectively (Yanxia Li et al., Mol Cancer Ther (2013) 12 (11_Supplement): A235). Treatment with this antibody reduced murine macrophage viability in vitro and reduced macrophage migration. This antibody was evaluated in several murine tumor models and shown to have good in vivo efficacy (Yanxia Li et al, Mol Cancer Ther (2011) Abstract C224). When dosed in vivo, CS7 increased the level of circulating CSF-1 (EP3380521). In murine models of breast cancer using CSF-1-secreting MDA-MB-231, Hcc1954, 4T1 or EMT6 tumor cells, CS7 treatment led to a marked reduction in tumor associated macrophages and an associated decrease in tumor growth. In breast tumor cell lines JimT1 and MCF-7 had limited or no decrease in tumor volume following CS7 treatment. In prostate models, DU145 tumor cell line xenografts (CSF-1-secreting) but not PC3 (CSF-1 non-secreting) tumor growth was inhibited by CS (Mol Cancer Ther (2013) 12 (11_Supplement): A235).
Antibody First Published
Yanxia Li et al. Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models. Mol Cancer Ther (2011) 10 (11_Supplement): C224. PMID:
Note on publication
This paper summarizes the in vitro and in vivo characterization of an anti-mouse CSF-1R antibody.
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.

 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号